News
-
-
-
-
PRESS RELEASE
THERANEXUS JOINS UP WITH SYNERLAB TO PREPARE THE COMMERCIALIZATION OF ITS PEDIATRIC FORMULATION IN NIEMANN-PICK TYPE C DISEASE
Theranexus partners with Synerlab to produce oral solution of miglustat for Niemann-Pick type C disease, aiming for EMA approval and commercialization by 2026. Novel pediatric formulation Mig-OS provides new therapeutic option for NPC patients -
-
-
-
-
PRESS RELEASE
Electrovaya Receives Funding from the Government of Canada
Electrovaya secures C$2 million government funding for automation and capacity enhancements at its Canadian facility to support lithium ion battery technology. CEO Dr. Raj DasGupta expresses gratitude for the support. Minister Filomena Tassi emphasizes commitment to net-zero emissions and EV industry growth in Southern Ontario -